To get there, we must:
Exploit automation technologies to scale complex 3D biology research in a high throughput screening environment
Increase access to organoids pioneering a future where researchers are empowered to personalize therapies, improving global health
Commercialize fully-integrated screening solutions bringing end-to-end workflows together connecting cell line development with 3D biology
Maximize use of artificial intelligence to guide data-driven analysis and decision-making across the entire drug discovery process
Made with FlippingBook. PDF to flipbook with ease